Innovative Treatment for SOD1-ALS, a Genetic Form of ALS, Brings Hope to Community

ALS Canada-supported research helped pave the way for the first Health Canada-approved treatment for a genetic form of ALS.

- Tania Amardeil

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that causes motor neuron degeneration, leading to paralysis and, ultimately, death. An estimated 4,000 Canadians are currently living with ALS, and 80 per cent of patients die within two to five years of diagnosis.